Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research
21 Nov 2024
Brussels, 21 November 2024 – The European Organisation for Research and Treatment of Cancer (EORTC) was honoured to welcome Minister Frank Vandenbroucke, Belgian Minister of Social Affairs and Public Health, to its headquarters in Brussels on 21 November 2024. This visit emphasised the ongoing commitment to optimise the way cancer treatments are used and improving patient outcomes through collaborative efforts.
During his visit, Minister Vandenbroucke and EORTC’s representatives discussed the latest advancements in cancer research and treatment. The discussions focused on the role of EORTC in clinical cancer research, the challenges in running independent clinical trials in the EU regulatory landscape, and the integration of cancer research and care.
Minister Vandenbroucke’s visit highlights the Belgian government’s dedication to supporting scientific research and fostering international collaborations.
“Cancer research is a global challenge that requires a united effort. By working together, all stakeholders can accelerate access to efficient treatments and improve the quality of life for patients worldwide,” said Minister Vandenbroucke. He continues saying “We are proud for Belgium to host the headquarters of EORTC, a leading clinical cancer research organisation worldwide”.
EORTC CEO, Dr. Denis Lacombe, expressed his enthusiasm for the visit, stating, “We were delighted to host Minister Vandenbroucke and showcase the impactful work being done at EORTC. His support is invaluable in our mission to conduct high quality independent clinical research and provide better treatment options for patients.”
The visit addressed ongoing priorities and the future of clinical cancer research in the EU to continue delivering therapeutic progress for all cancer patients. This event marks a significant step forward in the fight against cancer, reinforcing the importance and the value of independent research networks in the EU to contribute to the evolution of multidisciplinary standards of care.
About EORTC
The European Organisation for Research and Treatment of Cancer (EORTC) is a non-governmental, non-profit organisation, which unites clinical cancer research experts, throughout Europe, to define better treatments for cancer patients to prolong survival and improve quality of life. Spanning from translational to large, prospective, multi-centre, phase III clinical trials that evaluate new therapies and treatment strategies as well as patient quality of life, its activities are coordinated from EORTC Headquarters, a unique international clinical research infrastructure, based in Brussels, Belgium.
Contact
Caroline Moulins
Head of Communications
caroline.moulins@eortc.org
Related News
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
11 Dec 2024
IMMUcan has completed patient enrolment
12 Nov 2024
EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients
5 Nov 2024
Pink October at EORTC: Over 60 years of impactful breast cancer research
29 Oct 2024
Spotlight on ENA 2024 News
25 Oct 2024
Do regulations and policies undermine the social value of independent academic research?
25 Oct 2024
EORTC Quality of Life Group’s participation to ISOQOL 2024
10 Oct 2024
New Insights into Glioblastoma Treatment for Older Adults Patients
8 Oct 2024
TOPGEAR trial results show no significant benefit of preoperative chemoradiotherapy on long term survival
24 Sep 2024
New results and forthcoming EORTC trials in prostate cancer, melanoma, head and neck, lung, rare, and breast cancers presented at ESMO 2024
17 Sep 2024